Simron Singh: (Webcast presented by the Press office of ASCO-GI)

4 Views
administrator
administrator
07/09/23

Simron Singh MD, MPH, FRCP(C). Efficacy and safety of everolimus in advanced, progressive, nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract and unknown primary: A subgroup analysis of the phase III RADIANT-4 trial.[nbsp]Abstract 315

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next